Boston - Two medical technology companies, OmniGuide™ Holdings (OGH) and UROTECH®, a subsidiary of Medi-Globe Group, announced on February 24 that they have formed a groundbreaking partnership to improve urology patient therapies on a global scale.
The collaboration marks a strategic move to strengthen UROTECH's technology portfolio, with a particular focus on advancing the treatment of kidney stones and benign prostatic hyperplasia (BPH) through the use of RevoLix™ HTL (Hybrid Thulium Laser Therapy).
UROTECH, known for its commitment to quality standards and innovative solutions in minimally invasive urology, sees this partnership as a significant step in its mission to support urologists worldwide. Dr. Markus Schönberger, Director of Business Development and Head of the Strategic Business Unit Urology at Medi-Globe Group, emphasized UROTECH's customer-focused approach and its commitment to bringing cutting-edge technologies to its customers.
OmniGuide, recognized for its advancements in robotics, precision light therapies and biosensing software, brings its expertise to the collaboration to provide comprehensive solutions for a range of urological procedures. M.T. Henderson, CEO of OmniGuide Holdings, emphasized the importance of innovative therapies in improving patient outcomes and expressed his pride in the potential of this partnership to positively impact the lives of patients.
Key initiatives of the partnership include scaling global capacity for kidney stone and BPH treatments, implementing user-centric strategies for urologists, increasing advocacy through partnerships, and developing a biosensing software platform in collaboration with the OmniGuide Institute for Biomedical Innovation.
With OmniGuide headquartered in Billerica, Massachusetts, USA, and UROTECH based in Achenmühle, Bavaria, Germany, this collaboration underscores a commitment to global cooperation in advancing medical technology and improving patient care.
OmniGuide Holdings, headquartered in Billerica, Massachusetts, USA, is engaged in the design, development and marketing of advanced energy surgical devices focused on patient safety. UROTECH, a Medi-Globe company and subsidiary of DCC Healthcare, provides medical technology solutions in the field of urology. Headquartered in Achenmühle, Bavaria, Germany,
.
